Scarica l'app Stockscreener
3.94
1.03%
0.04
Pre-mercato:
4.04
0.10
+2.54%
Precedente Chiudi:
$3.90
Aprire:
$3.88
Volume 24 ore:
923.25K
Relative Volume:
1.02
Capitalizzazione di mercato:
$501.26M
Reddito:
$193.01M
Utile/perdita netta:
$-12.15M
Rapporto P/E:
-43.78
EPS:
-0.09
Flusso di cassa netto:
$454.00K
1 W Prestazione:
-5.06%
1M Prestazione:
-0.76%
6M Prestazione:
+2.07%
1 anno Prestazione:
-22.90%
Intervallo 1D:
$3.795
$3.94
Intervallo di 1 settimana:
$3.705
$4.22
Portata 52W:
$2.37
$7.63
Cytek Biosciences Inc Stock (CTKB) Company Profile
Nome
Cytek Biosciences Inc
Settore
Industria
Telefono
(877) 922-9835
Indirizzo
47215 LAKEVIEW BOULEVARD, FREMONT
Confronta CTKB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
3.94 | 496.17M | 193.01M | -12.15M | 454.00K | -0.09 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-09 | Downgrade | TD Cowen | Buy → Hold |
| 2025-01-31 | Downgrade | Goldman | Buy → Sell |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-07-19 | Iniziato | Raymond James | Mkt Perform |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
What To Expect From Cytek Biosciences Inc (CTKB) Q3 2025 Earnings - GuruFocus
Can Cytek Biosciences Inc. (8EQ) stock sustain revenue momentumEarnings Risk Report & Free Real-Time Volume Trigger Notifications - newser.com
How Cytek Biosciences Inc. stock reacts to bond yields2025 EndofYear Setup & Fast Entry High Yield Tips - newser.com
Multi factor analysis applied to Cytek Biosciences Inc.Index Update & Risk Controlled Daily Trade Plans - newser.com
How supply chain issues affect Cytek Biosciences Inc. stockRisk Management & Free Community Consensus Stock Picks - newser.com
Is Cytek Biosciences Inc. (8EQ) stock overpriced at current multiplesJuly 2025 Summary & Proven Capital Preservation Methods - newser.com
Is Cytek Biosciences Inc. stock supported by innovation pipelineMarket Risk Analysis & Safe Entry Zone Tips - newser.com
Can Cytek Biosciences Inc. stock maintain growth trajectoryQuarterly Profit Summary & Weekly Top Performers Watchlists - newser.com
Does Cytek Biosciences Inc. stock trade at a discount to peersWeekly Risk Report & Capital Efficiency Focused Strategies - newser.com
Can a trend reversal in Cytek Biosciences Inc. lead to recovery - newser.com
Comparing Cytek Biosciences Inc. in custom built stock radarsBull Run & Weekly High Potential Stock Alerts - newser.com
Smart tools for monitoring Cytek Biosciences Inc.’s price actionGold Moves & Short-Term Trading Alerts - newser.com
Applying Elliott Wave Theory to Cytek Biosciences Inc.July 2025 Sentiment & Fast Gain Swing Trade Alerts - newser.com
Will Cytek Biosciences Inc. (8EQ) stock beat growth indexesJuly 2025 Recap & Technical Buy Zone Confirmations - newser.com
Understanding Cytek Biosciences Inc.’s price movementJuly 2025 PostEarnings & Verified Trade Idea Suggestions - newser.com
How strong dollar benefits Cytek Biosciences Inc. (8EQ) stockQuarterly Portfolio Review & Proven Capital Preservation Methods - newser.com
Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cytek Biosciences Inc Azioni (CTKB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| McCombe William D. | Chief Financial Officer |
Jun 02 '25 |
Buy |
2.78 |
35,000 |
97,300 |
55,746 |
1.84%
0.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):